Mixed Deck — All NRCME Topics Flashcards

An ITDM exemption holder is 3 hours into a long-haul drive and performs the required en-route glucose check. His reading is 68 mg/dL. He feels fine and attributes it to skipping a snack. He wants to pull over, eat glucose tablets, and resume driving in 20 minutes. Why is this plan non-compliant with exemption program requirements?

Answer: He must wait at least 45 minutes after treatment and confirm blood glucose ≥100 mg/dL before resuming

When a blood glucose reading falls below 100 mg/dL during a CMV trip, ITDM exemption program requirements mandate that the driver stop driving immediately, treat the hypoglycemia, and wait a minimum of 45 minutes before rechecking. Driving may only resume if the post-treatment glucose is ≥100 mg/dL. A 20-minute wait is insufficient — glucose counterregulation and symptom resolution take time, and the driver may still be impaired even if subjectively feeling fine due to the delayed physiologic response.

Which statement best describes the purpose of the urinalysis in the FMCSA commercial driver medical examination?

Answer: It screens for medical conditions that may affect driving safety

The DOT urinalysis is a medical screening tool to detect conditions such as diabetes and renal disease that could impair driving safety, not a regulated drug test.

A truck driver has a history of cervical spine fusion at C5-C6. Which examination finding would be most concerning for certification?

Answer: Cervical rotation limited to 15 degrees bilaterally with inability to check blind spots

Severely restricted cervical rotation prevents adequate blind-spot checking, directly impairing safe driving ability.

Which tool is most appropriate to quantitatively assess grip strength during a NRCME musculoskeletal examination?

Answer: Jamar dynamometer

The Jamar dynamometer is the standard validated tool for measuring grip strength in clinical and occupational health settings.

Which federal form is used by the medical examiner to document the results of the physical examination including vision and hearing findings for CMV drivers?

Answer: MCSA-5875

The MCSA-5875 is the Federal Motor Carrier Safety Administration Medical Examination Report form used to document all examination findings.

Under FMCSA guidelines, a driver using an oral hypoglycemic agent (e.g., metformin) with no insulin use and an A1c of 6.8% should be:

Answer: Certified under standard medical criteria if no hypoglycemia risk or other disqualifying conditions

Oral hypoglycemic agents not causing hypoglycemia do not trigger the insulin exemption requirement, and well-controlled diabetes on such therapy is certifiable.

During a DOT physical, a driver reports needing a hearing aid to perceive a forced whispered voice at 5 feet. The driver successfully passes the whisper test while wearing the device. The medical examiner should:

Answer: Certify the driver and note on the medical certificate that a hearing aid is required while driving

The FMCSA standard (49 CFR 391.41(b)(11)) allows drivers to use a hearing aid to meet the requirement of perceiving a forced whispered voice at not less than 5 feet in the better ear. When a hearing aid is necessary to meet the standard, the medical examiner records this on the Medical Examiner's Certificate (MEC) as a required operating condition. The driver must then wear the hearing aid whenever operating a CMV — failure to do so would place them out of compliance with their certification.

Which of the following blood pressure readings allows for a 2-year medical certification, assuming the driver has no other disqualifying conditions and is not on any antihypertensive medication?

Answer: 136/84 mmHg

To qualify for a 2-year medical certificate, a driver must have a blood pressure reading of less than 140/90 mmHg and not be on medication for hypertension. A reading of 136/84 mmHg meets these criteria. The other readings are either at or above the 140/90 mmHg threshold.

A driver has a diagnosis of obstructive sleep apnea but refuses CPAP therapy. What is the appropriate FMCSA certification action?

Answer: Do not certify until effective treatment is documented

Untreated obstructive sleep apnea poses a risk of sudden incapacitation; certification should not be issued until adequate treatment compliance is demonstrated.

A 58-year-old commercial driver reports intermittent diplopia only when fatigued. Visual acuity is 20/20 in each eye separately, and there is no spontaneous deviation at rest. Which finding during the physical examination would most appropriately lead to disqualification under FMCSA standards?

Answer: A measurable phoria that breaks into a manifest tropia under the cover-uncover test

FMCSA regulations require the ability to recognize colors and have adequate field of vision, but a phoria that breaks into a manifest tropia (heterotropia) under dissociation represents a true binocular vision deficit that can cause sudden diplopia during driving. A phoria alone may be compensated, but when it decompensates into a tropia under the cover-uncover test, it signals the driver cannot reliably maintain single binocular vision — a disqualifying condition. Isolated phoria, stereoacuity deficits, and near-only fusion issues are not independently disqualifying under the federal standards.

Which of the following is a disqualifying condition related to alcohol use under FMCSA medical standards?

Answer: Current clinical diagnosis of alcoholism

FMCSA regulations disqualify drivers with a current clinical diagnosis of alcoholism regardless of treatment history.

During a CMV medical examination, a driver discloses he had a transient ischemic attack (TIA) 5 months ago with full neurological recovery confirmed within 24 hours. He has no residual deficits. Imaging showed no infarct; the TIA was attributed to a patent foramen ovale (PFO) which was subsequently closed via percutaneous procedure 3 months ago. He provides a cardiology clearance letter. Which of the following BEST describes the examiner's obligation?

Answer: Disqualify for a minimum of 1 year from the TIA event, regardless of PFO closure or specialist clearance

A TIA is treated similarly to stroke under FMCSA cardiovascular standards. Even with full recovery and PFO closure, the FMCSA advisory criteria specify that a driver should not be certified for at least 1 year following a TIA to allow for sufficient risk-free observation and to rule out recurrent cerebrovascular events. The corrective PFO closure reduces future risk but does not eliminate the mandatory waiting period or the underlying cerebrovascular risk profile. Specialist clearance is advisory; the 1-year post-event period before recertification reflects the regulatory standard.

An applicant for CDL certification discloses a history of bilateral hip replacement (total arthroplasty) performed 3 years ago with excellent functional outcome. He demonstrates full painless ROM of the hips, 5/5 lower extremity strength, and normal gait. He takes no medications. Which statement BEST reflects FMCSA's position?

Answer: Total hip arthroplasty is not a listed disqualifying condition; certify if examination confirms adequate functional capacity

FMCSA's physical qualification standards do not list total hip arthroplasty — unilateral or bilateral — as a disqualifying condition or as a condition requiring a federal exemption. The medical examiner assesses functional capacity: ROM, strength, gait, and ability to perform CMV-related tasks. This driver has full ROM, normal strength, and no pain — there is no basis to restrict, defer, or require specialist clearance. Late aseptic loosening is a chronic process that does not cause sudden incapacitation analogous to seizure or cardiac arrest.

During a commercial driver examination, which test method is used to assess color vision under FMCSA guidelines?

Answer: Any test that assesses the ability to recognize traffic signal colors

FMCSA requires the ability to distinguish red, green, and amber but does not mandate a specific color vision test instrument.

What is the Medical Examiner's Certificate (MEC) form number issued to a qualified commercial driver?

Answer: MCSA-5876

Form MCSA-5876 is the Medical Examiner's Certificate issued to drivers who pass the DOT physical examination.

A driver being treated for hypertension takes clonidine. Which side effect should the CME specifically ask about?

Answer: Sedation and drowsiness

Clonidine, a central alpha-2 agonist, commonly causes sedation and drowsiness, which can significantly impair a driver's alertness and reaction time.

A driver applying for a vision exemption must submit which type of supporting documentation to FMCSA?

Answer: An ophthalmologist or optometrist evaluation confirming vision status and driving safety

A vision exemption application requires a specialist evaluation from an ophthalmologist or optometrist documenting the driver's vision status and safety to operate.

A driver with stable angina managed with nitroglycerin as needed is seeking a DOT medical certificate. The NRCME examiner should:

Answer: Refer for exercise stress testing and cardiology evaluation before certifying

Angina suggests myocardial ischemia, which carries risk of sudden cardiac events; stress testing and cardiology evaluation are needed to assess actual risk before certification.

During a certification exam, a medical examiner notes that a driver requires the use of portable supplemental oxygen for a chronic respiratory condition. Which of the following is the most appropriate determination regarding this driver?

Answer: Disqualify the driver

The use of supplemental oxygen therapy while driving is a disqualifying condition according to FMCSA guidelines. This is due to concerns about the reliability of the equipment, the risk of fire or explosion, and the severity of the underlying lung disease that necessitates oxygen use.

During the neurological examination of a CMV driver, the CME observes a resting tremor and pill-rolling movements. What is the most appropriate next step?

Answer: Refer for neurological evaluation before making a certification decision

Signs suggestive of Parkinson's disease require specialist evaluation to assess functional impact before a certification determination can be made.